Safwan Shabab

Safwan Shabab is a Principal at TPG since 2019, with extensive experience in investment and board oversight across various companies. Currently, Safwan serves as a Board Observer for Confluent Medical Technologies and LifeStance Health, having also held a similar role at Immucor, Inc. until March 2023. Prior experience includes positions as an Investment Professional at Onex and as an Associate at Cressey & Company, along with an Analyst role at Barclays Investment Bank. Safwan holds an MBA from Harvard Business School, an MPP from Harvard Kennedy School, and a BA from Colgate University.